Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

Clinical trial NCT03392207 · COMPLETED

Trial details

NCT number: NCT03392207
Sponsor: Butantan Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza, Human Orthomyxoviridae Infections RNA Virus Infections Respiratory Tract Infections Virus Diseases Vaccines Physiological Effects of Drugs

Start date: 2018-04-23
Primary completion: 2018-07-17
Enrollment: 403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.